Arecor to present on Investor Meet Company

Arecor Therapeutics plc

("Arecor" or the "Company")

Arecor to present on Investor Meet Company platform

Cambridge, UK, 24 April 2025: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today's therapies to enable healthier lives, today announces that Sarah Howell, Chief Executive Officer, and David Ellam, Chief Financial Officer, will be providing a live presentation of the Group's recently announced final results for the year ended 31 December 2024 via the Investor Meet Company platform on Thursday 1 May 2025 at 2pm BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 30 April 2025, 09:00 BST, or at any time during the live presentation.

To sign up to Investor Meet Company for free and to register for Arecor's presentation, please visit:

https://www.investormeetcompany.com/companies/arecor-therapeutics-plc

Investors who already follow Arecor on the Investor Meet Company platform will automatically be invited to the event.

-ENDS-

For more information, please contact:

Notes to Editors

About Arecor

Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio. For further details please see our website, www.arecor.com